Andrew Moin - Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SABS, SABSW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Moin since 11 Mar 2025

Holdings reported by Andrew Moin for SAB Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,198,457 $3,847,299 $1.75 29 Sep 2025 Indirect
Series B Convertible Preferred Stock 211,100 29 Sep 2025 Indirect Common Stock
Warrants (right to buy) 114,250 22 Jul 2025 Indirect Series B Convertible Preferred Stock

Transactions reported by Andrew Moin for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.